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Are Not Synthesized by Rat and Mouse Megakaryocytes
Prom Handagama,* Daniel A. Rappolee,t Zena Werb,t Jack Levin,611 and Dorothy F. Bainton*
*Department ofPathology, *Laboratory ofRadiobiology and Environmental Health, and IDepartment ofLaboratory Medicine,
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San Francisco, California 94121

Abstract
It has been assumed that endogenous synthesis by the platelet
precursor cell, the bone marrow megakaryocyte, is the major
source of platelet a-granule protein. To test this hypothesis, we
used mRNA phenotyping to detect in megakaryocytes the
presence of mRNA transcripts specific for various proteins.
Our results indicate that megakaryocytes synthesize platelet
factor 4, a protein relatively specific for platelets, but do not
express mRNA transcripts for the fibrinogen, albumin, or IgG
found in a-granules. We have previously shown that megakaryocytes endocytose circulating proteins, including fibrinogen, albumin, and IgG, and incorporate them into a-granules.
Thus, platelets appear to contain a unique type of secretory
granule whose contents originate by both endogenous synthesis
and endocytosis from plasma. Under basal conditions, the
source of a-granule fibrinogen is plasma. (J. Clin. Invest.
1990. 86:1364-1368). Key words: plasma proteins * PCR.
mRNA phenotyping - secretory granule

Introduction
The function of many tissues and cells is delineated by the
specific proteins they synthesize and secrete. The secretory
granules of neutrophils and cells of the pancreas and the salivary gland have been studied extensively, and the biosynthetic
route of their cell-specific proteins has been elucidated (1, 2).
In these cell types, the proteins are endogenously synthesized
and then packaged into granules. Platelets are anucleate cells
that secrete the contents of their main storage organelles, the
a-granules, at sites of vascular injury. The secreted substances,
together with coagulation proteins from plasma, contribute to
the formation of a hemostatic plug. Platelets arise from bone
marrow precursor cells called megakaryocytes. a-Granule
proteins such as fibrinogen and platelet factor 4 (PF-4),' albuAddress reprint requests to Prem Handagama, Dept. of Pathology,
University of California, HSW-50 1, San Francisco, CA 94143-0506.
Received for publication 1 June 1990 and in revisedform 13 July
1990.

1. Abbreviations used in this paper: PF-4, platelet factor 4;
reverse transcription-polymerase chain reaction.
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min, and IgG are immunohistochemically detectable in megakaryocytes (3, 4). Platelet fibrinogen, the predominant protein
secreted from a-granules, has been assumed to be synthesized
by megakaryocytes. Reports have indicated that megakaryocyte-enriched marrow preparations synthesize fibrinogen (5, 6)
and contain fibrinogen-specific mRNA (7). However, when
IgG was localized to a-granules, the hypothesis of endocytic
origin of platelet granule proteins was presented (8). There is
recent evidence to support this hypothesis. First, we and others
have shown that when several proteins, including fibrinogen,
albumin, and IgG, are administered intravenously, they are
rapidly endocytosed by megakaryocytes and incorporated into
a-granules (3, 9-12). These proteins are later secreted by platelets after stimulation with thrombin. Second, when rats are
maintained in a defibrinated state by injections of a snake
venom enzyme (ancrod) that specifically degrades fibrinogen
and removes it from the circulation, the megakaryocytes and
platelets contain markedly reduced amounts of fibrinogen
(13). Because the megakaryocyte, a cell with abundant rough
endoplasmic reticulum, is thought to be the site where most
platelet proteins are synthesized (14, 15), we undertook this
study to determine whether megakaryoctes can synthesize
these proteins.

Methods
Preparation of cellular RNA. Rat bone marrow megakaryocytes were
enriched by a two-step process of density gradient centrifugation and
velocity sedimentation as previously described (15), except that all
procedures were carried out at 10'C, and unit gravity sedimentation
was used instead of centrifugation on a continuous Ficoll gradient.
Bone marrow megakaryocytes (2-5 X 10') at 85% to 90% purity were
processed by a microprocedure for RNA isolation that included adding
20 jug of carrier Escherichia coli rRNA to each preparation (16, 17).
Mouse megakaryocyte colonies were grown in soft agar cultures as
described previously (18-20). These colonies, composed entirely of
megakaryocytes, developed in culture from megakaryocyte colonyforming cells (10-20 cells per colony). Colonies (30-50 with a total of
500-800 megakaryocytes) were harvested directly into guanidine
isothiocyanate solution containing 20 ,g of E. coli rRNA (16, 17), and
whole RNA was purified.
RNA phenotyping by reverse transcription-polymerase chain reaction (RT-PCR). RNA was reverse-transcribed with 100 U of Moloney
murine leukemia virus reverse transcriptase (Bethesda Research Laboratories, Gaithersburg, MD) as previously described (16, 17), except
that 2 Iug of carrier E. coli rRNA was added to each reaction, and
primed by random hexanucleotides or oligo(dT). One-tenth of the RT
mixture was used in a PCR amplification primed by sequence-specific
oligonucleotides (listed in Table I [21-26]) for 60 cycles, as described
-
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Table I. Design of Oligonucleotide Primers Usedfor RT-PCR
5'Oligonucleotide (site
in sequence)

Transcript

3'Oligonucleotide
(site in sequence)

Diagnostic
restriction

Fragment
length

enzyme

bp

bp

Albumin
a-Fibrinogen

446-467
5738-5764
517-546
1006-1030
161-170,424-437
25-48
2063-2086

#-Fibrinogen
y-Fibrinogen
PF-4

fl-actin
IgG (CK)

1765-1743
6766-6748
699-673
1247-1225
744-723
268-245
4803-4780

Diagnostic
fragment
lengths

322
373
172
241
192
243
223

Hinc II

Apa I
Rsa I

Taq I
Bam HI

Bgl II
Hpa I

218 +
314 +
96 +
183 +
118 +
152 +
135 +

104
59
76
58
74
91
88

Sequences are from published sources (21-26).

previously (16, 17). 8 gl of the 50 jtl PCR mixture was electrophoresed
in 4% agarose, and then stained with ethidium bromide as described
(16, 17). Products of the RT-PCR were validated by predicted size,
restriction enzyme analysis, or DNA bolt analysis.
Calculations. To calculate the minimum threshold number of
mRNA transcripts per megakaryocyte, we first calculated the minimum threshold for detection of each mRNA species in the positivecontrol rat liver RNA. Each liver cell contains 100 pg of RNA (27),
3,000 transcripts of fibrinogen (28; Crabtree, G. R., personal communication), and 10,000 transcripts of albumin (Fausto, N., personal
communication). We calculated the minimum threshold for number
of transcripts by multiplying the number of transcripts in a liver cell by
a ratio of the detection threshold for the species (in picograms, given in
Table II) to the 100 pg of total RNA in a liver cell (27). Thus, (10,000
transcripts of albumin mRNA per liver cell) X (1 pg detection threshold for albumin) + (100 pg RNA per liver cell) gives a minimum
threshold of 100 transcripts of albumin.
The threshold for number ofRNA transcripts in a single megakaryocyte from a colony was calculated by first multiplying the number of
megakaryocytes harvested by the fraction of purified RNA recovered
(determined from recovery of the carrier rRNA because this was in
large excess of the megakaryocyte RNA) to give the number of megakaryocytes used in the RT reaction. The number of megakaryocytes in
each PCR reaction tube was determined by dividing the number of

megakaryocytes in the RT reaction by the number of PCR tubes into
which the RT mix was aliquoted. The threshold of a given mRNA
species in the liver was then divided by the number of megakaryocytes
in each PCR tube. In a typical experiment, RNA from 1,200 colony
megakaryocytes was recovered at 66% yield and then analyzed in four
PCR reaction tubes, giving 200 megakaryocytes in each PCR tube.
With a detection threshold of 100 albumin transcripts for 200 megakaryocytes, 0.5 transcripts (or less) per colony megakaryocyte would be
detected.
The threshold for number of mRNA transcripts in a single megakaryocyte in a megakaryocyte-enriched bone marrow preparation was
determined by multiplying the total number of bone marrow cells by
the percentage that were megakaryocytes and multiplying that number
by the percentage of RNA recovered. This yielded the number of
megakaryocytes per RT reaction. This number was divided by the
number of PCR tubes per RT reaction to yield the number of megakaryocytes per PCR tube. The detection threshold for a given mRNA
species in liver was then divided by the number of megakaryocytes in
each PCR tube. In a typical experiment, RNA from 50,000 bone
marrow cells consisting of 90% megakaryocytes was recovered at a
yield of 66%. If one-tenth ofthe RNA was analyzed in each PCR tube,
then each reaction contained 3,000 megakaryocytes. For albumin,
0.03 transcripts (or less) per bone marrow megakaryocyte would be
detected.
-

Table II. Summary of mRNA Transcripts Expressed in Bone Marrow and Megakaryocytes (mk)
Calculated threshold for No. of mRNA transcripts
Presence of transcript

Whole

Transcript

marrow

Enriched
mk

Pure mk

colonies

Detection threshold
of species in positive
control RNA

Positive
control
RNA

Enriched
mk

Pure mk

3000
3000
300
100
NC
NC

< 1.0
<1.0
<0.01
<0.03
NC
NC

. 15

colonies

Pg

Fibrinogen
a

ft

+(I)

-(5)
-(3)

-(3)
-(3)

ly

+(2)

+(4)*

-(3)

-(2)

-(4)

-(1)

Albumin

+(2)

IgG (CK)

+(I)

±(I)*

-(1)

PF-4

+(2)

+(4)

+(3)

100
100
10
1
1
100

C15

<1.5
<0.5
NC
NC

Samples that were positive for the specific mRNA transcripts by RT-PCR are indicated by "+", those that were negative by "-", and those that
were variable by "±". The number of experiments, each performed with two or three replicate RNA preparations, is shown in parentheses. Detection thresholds were determined with whole liver RNA, except for CK, which was determined with mouse spleen RNA. The minimum
thresholds for number of mRNA transcripts in positive control RNA and megakaryocytes were derived by calculation (see Methods). NC, not
calculated. * One positive result was obtained with a preparation that had only -50% megakaryocytes.
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Figure 1. Expression of mRNA for a, fS, or y fibrinogen, allbumin, or
IgG in various cell types. (a) Example of the determination of the detection threshold of a species (albumin) in a dilution series of 10-fold
positive control (whole rat liver) RNA processed by RT-PC 'R for 60
cycles. The thresholds of all RT-PCR reactions are given in Table II.
The amount of RNA in each PCR reaction is indicated on ' the abscissa (in pg); M is the ladder of molecular weight markers ((Bethesda
Research Labs) (in bp). (b) Test of oligonucleotide primers by RTPCR for sources of each specific mRNA. Whole RNA from duplicate samples of 100 ng of rat liver (source of a, (3, y fibrinof gen, albumin, and fl-actin) or mouse spleen (source of CK) was revertse-transcribed, primed by oligonucleotides, amplified by 60 cycles of PCR,
and then analyzed by electrophoresis in 4% agarose gels, fol[lowed by
staining with ethidium bromide. Duplicate preparations are shown
for each primer pair. All photographs are presented as negatiye images.

because 90% of mouse and rat IgGs have K chains. However, in
neither the enriched rat megakaryocyte preparations
(85%-90% pure) (Fig. 2 a) nor the pure mouse megakaryocyte
colonies grown for seven days (Fig. 2 b) could mRNA transcripts for fibrinogen (a, (3, y), albumin, or IgG (CK) be detected. Transcripts for fibrinogen (y) also were not detected in
immature megakaryocyte colonies grown for three or five days
(data not shown). In contrast, mRNA transcripts for PF-4 (Fig.
2 a, b) and f3-actin (Fig. 2 a, b) were easily seen in these samples. The identities of PCR fragments were validated by cutting with restriction enzymes (Fig. 3). Although megakaryocytes of > 85% purity did not contain detectable mRNA transcripts for fibrinogen, these transcripts were detected in whole
bone marrow and in one preparation with 50% megakaryocytes (Table II). IgG transcripts were detected in whole bone
marrow but not in the pure megakaryocyte colonies. Albumin
was not detected in any sample, even though < 0.03 transcripts per bone marrow megakaryocyte would have been detected.
Since the RT-PCR technique was sensitive enough to have
detected less than one mRNA transcript per megakaryocyte,
we conclude that megakaryocytes do not synthesize fibrinogen, albumin, or IgG. These data, taken together with previous
observations (3, 9-12), indicate that megakaryocytes incorporate the fibrinogen, albumin, and IgG found in their a-granules from plasma.
Our results with fibrinogen conffict with those of previous
investigators (5-7), who reported that fibrinogen is synthesized
by megakaryocytes in 50%-80% pure preparations; however,
an earlier study failed to show fibrinogen synthesis in cultured
megakaryocytes (31). The structure and function of platelet
fibrinogen is also a much disputed subject. Although some
investigators have suggested that platelet fibrinogen is different
from plasma fibrinogen (32), many of these differences may be

~~~~a

I

Results and Discussion
We used the method of mRNA phenotyping to detec stmRNA
transcripts for specific proteins in small numbers of cells.
Megakaryocyte RNA was obtained from three typees of cell
preparations: (a) whole rat bone marrow, in which 0.16% of
r
the cells are megakaryocytes, (b) megakaryocyte-enr h tA
bone marrow, in which 85%-90% of the cells are larj gely stage
II and III megakaryocytes (29), and (c) mouse megal karyocyte
colonies grown in vitro for seven days. The latter two preparations correspond to the stage at which fibrinogen is Iknown to
appear in megakaryocytes (30). RNA from immatuIre megakaryocytes, present in megakaryocyte colonies after-three or
five days of culture, was also analyzed. The colonies obtained
from cultures served as the source of completely pu re megakaryocytes, free of contamination by other cell types. Samples
of mouse and rat liver, spleen, and macrophage R NA were
purified and used as positive controls.
RT-PCR was sensitive enough to detect albumin (Fig. 1 a),
the three chains of fibrinogen (a, (3, y), and fl-actin in less than
a single rat or mouse liver cell. PF4 could be detect,ed in less
than 100 pg of megakaryocyte RNA. RT-PCR alsoLdetected
mRNA transcripts for IgG in spleen (Fig. 1 b); prime rs for the
constant region of mouse IgG-K light chain (CK) Mvere used
-
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Figure 2. (a) RT-PCR of purified rat bone marrow megakaryocytes.
(3-actin and PF-4 are endogenous megakaryocyte proteins used as
positive controls. Duplicate preparations from one of two or three
experiments are shown for each primer pair. (b) RT-PCR of mouse
megakaryocyte colonies grown in soft agar cultures for seven days.
Duplicate preparations from one of three experiments are shown for
each primer pair. M, the molecular weight markers as shown in Fig.
I a.

P. Handagama, D. A. Rappolee, Z. Werb, J. Levin, and D. F. Bainton

46

_

"

IIIs

Ii

-4
C
M

U

C kappa

C

LUI

C

ULI

alpha

C

LI

gamma
beta
fibrinogen ifibrinogen fibrinogen

C

LU

albumin

betaactin

explained by y-chain heterogeneity and degradation during
purification (33-36). Our data suggest that bone marrow cells
other than megakaryocytes contain fibrinogen transcripts. In
preliminary experiments we found that some macrophages
and granulocyte-macrophage colonies contain fibrinogen-specific mRNA and/or immunohistochemically stainable fibrinogen (data not shown). Thus, previous results indicating that
megakaryocytes synthesize fibrinogen could be due to contamination with mRNA from other cells, such as macrophages. In
addition, it has been reported that megakaryocytes grown in
vitro contain fibrinogen only if the culture medium contains
fibrinogen (30). These observations are in accord with the present data showing that megakaryocytes cannot synthesize fibrinogen.
The uptake and incorporation of fibrinogen into granules
by megakaryocytes and platelets is probably mediated by receptors. Assuming a normal human platelet volume of 9.6 fl
(37) and an a-granule content of 8% of platelet volume (38),
the a-granule concentrations for fibrinogen (39), PF-4 (40),
albumin (41), and IgG (41) are 91.3, 41.3, 31.6, and 6.5 fg/fl,
respectively; the plasma concentrations for these proteins are
3.0, trace, 42.8, and 11.3 fg/fl, respectively. Thus, the ratios of
a-granule:plasma concentrations are 30.4, > 106, 0.7, and 0.6,
respectively. Note that the ratios of all three proteins not synthesized by megakaryocytes (fibrinogen, albumin, and IgG)
are much lower than that of the endogenously synthesized
PF-4. Because the concentration of fibrinogen, but not of albumin or IgG, is higher in a-granules than in plasma, the
uptake of fibrinogen may be more efficient. Megakaryocytes
and platelets possess the integrin glycoprotein (GP) Ilb-IIIa
complex, a well-characterized fibrinogen receptor (42). It is
tempting to hypothesize that this receptor mediates the uptake
of fibrinogen by megakaryocytes and platelets, because patients with Glanzmann's thrombasthenia, who have a congenital platelet GPIIb-IIIa deficiency, have an unexplained parallel
deficiency ofplatelet fibrinogen (43, 44). In'contrast, a-granule
albumin and IgG are probably acquired by fluid-phase endocytosis (45). This hypothesis is supported by the observed correlation between the concentrations of albumin and IgG in
platelets and plasma over a wide range of normal and abnormal values (41).
In summary, megakaryocytes and platelets appear to have
two mechanisms for acquiring proteins for their major secretory organelle, the a-granules. Some proteins, such as PF-4, are
endogenously synthesized, whereas others are endocytosed
from plasma. It may be possible to use the endocytic pathway
to insert pharmacological agents into platelet a-granules, perhaps by attaching a receptor recognition sequence to the drug.
-

PF 4

Figure 3. Restriction enzyme analysis of DNA fragments
generated by RT-PCR (arrows). The amplified fragments
(100 Al) were ethanol-precipitated and then digested with
the restriction enzymes indicated in Table I, according to
the manufacturer's instructions (Bethesda Research
Labs, Promega Biotech, Madison, WI, or New England
Biolabs, Beverly, MA). Paired digested (C) and undigested (U) fragments were fractionated on 4% agarose
gels and stained with ethidium bromide. M, the molecular weight markers as shown in Fig. I a.

This pathway could serve as a new way to deliver drugs to sites
of platelet activation, such as areas of vascular injury and
thrombi.
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